Search

No relevant pages have been found.

No relevant news have been found: 2

New drug for inherited breast and ovarian cancers shows promise in early trials

Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising... al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a... olaparib, breast cancer, ovarian...

New drug may help women with hereditary breast cancer

were given 100mg doses of a new drug called olaparib, while the other half received 400mg doses of the drug. Olaparib is one in a... breast cancer, PARP inhibitors, olaparib...

No relevant news have been found.